Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

Chalmers JD, Burgel P-R, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML

Open source

DOI
10.57711/fv02-wq16
Published
2025
Container
Not recorded
Publisher
Newcastle University
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.57711/fv02-wq16,
  title = {Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis},
  author = {Chalmers JD, Burgel P-R, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML},
  year = {2025},
  doi = {10.57711/fv02-wq16},
  url = {https://doi.org/10.57711/fv02-wq16}
}

RIS

TY  - JOUR
TI  - Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
AU  - Chalmers JD, Burgel P-R, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML
PY  - 2025
DO  - 10.57711/fv02-wq16
UR  - https://doi.org/10.57711/fv02-wq16
ER  - 

APA

ML, C. J. B. P. D. C. D. S. A. H. C. M. D. L. M. M. P. R. F. B. F. S. M. M. K. T. A. F. C. Z. M. F. C. Z. X. M. (2025). Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. https://doi.org/10.57711/fv02-wq16

Source records